Clinical trial
Clozapine vs. Olanzapine: An Effectiveness Study
NCT00169065 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clozapine vs. Olanzapine: An Effectiveness Study
- Lead sponsor
- Harvard Medical School (HMS and HSDM)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 1998
- Completion date
- June 30, 2002
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.